AU3584895A - Method of treating macular degeneration using tgf-beta - Google Patents
Method of treating macular degeneration using tgf-betaInfo
- Publication number
- AU3584895A AU3584895A AU35848/95A AU3584895A AU3584895A AU 3584895 A AU3584895 A AU 3584895A AU 35848/95 A AU35848/95 A AU 35848/95A AU 3584895 A AU3584895 A AU 3584895A AU 3584895 A AU3584895 A AU 3584895A
- Authority
- AU
- Australia
- Prior art keywords
- tgf
- beta
- macular degeneration
- treating macular
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000002780 macular degeneration Diseases 0.000 title 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US314916 | 1989-02-24 | ||
| US31491694A | 1994-09-28 | 1994-09-28 | |
| PCT/US1995/011316 WO1996009838A1 (en) | 1994-09-28 | 1995-09-08 | METHOD OF TREATING MACULAR DEGENERATION USING TGF-$g(b) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3584895A true AU3584895A (en) | 1996-04-19 |
Family
ID=23222051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU35848/95A Abandoned AU3584895A (en) | 1994-09-28 | 1995-09-08 | Method of treating macular degeneration using tgf-beta |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU3584895A (en) |
| WO (1) | WO1996009838A1 (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5688765A (en) * | 1992-04-21 | 1997-11-18 | The Schepens Eye Research Institute, Inc. | Ocular therapy in Sjogren's syndrome using topically applied androgensor TGF-β |
| US6378526B1 (en) | 1998-08-03 | 2002-04-30 | Insite Vision, Incorporated | Methods of ophthalmic administration |
| US6309374B1 (en) | 1998-08-03 | 2001-10-30 | Insite Vision Incorporated | Injection apparatus and method of using same |
| WO2001056606A1 (en) * | 2000-01-31 | 2001-08-09 | Santen Pharmaceutical Co., Ltd. | Remedies for ophthalmic diseases |
| US20070202186A1 (en) | 2006-02-22 | 2007-08-30 | Iscience Interventional Corporation | Apparatus and formulations for suprachoroidal drug delivery |
| US8197435B2 (en) | 2006-05-02 | 2012-06-12 | Emory University | Methods and devices for drug delivery to ocular tissue using microneedle |
| CN104758118B (en) | 2010-10-15 | 2018-04-06 | 科尼尔赛德生物医学公司 | For entering the device of eyes |
| EP4566672A3 (en) | 2012-11-08 | 2025-08-13 | Clearside Biomedical Inc. | Methods for the treatment of ocular disease in human subjects |
| US9539139B2 (en) | 2013-05-03 | 2017-01-10 | Clearside Biomedical, Inc. | Apparatus and methods for ocular injection |
| US10010447B2 (en) | 2013-12-18 | 2018-07-03 | Novartis Ag | Systems and methods for subretinal delivery of therapeutic agents |
| RU2540504C1 (en) * | 2013-12-26 | 2015-02-10 | Федеральное государственное бюджетное учреждение "Московский научно-исследовательский институт глазных болезней имени Гельмгольца" Министерства здравоохранения Российской Федерации | Method for prediction of risk of late retinal detachment in children with cicatrical retinopathy of prematurity |
| JP2017524419A (en) | 2014-06-20 | 2017-08-31 | クリアサイド バイオメディカル，インコーポレイテッド | Variable diameter cannula and method for controlling insertion depth for drug delivery |
| EP3413851B1 (en) | 2016-02-10 | 2023-09-27 | Clearside Biomedical, Inc. | Packaging |
| JP2019514581A (en) | 2016-05-02 | 2019-06-06 | クリアサイド バイオメディカル，インコーポレイテッド | Systems and methods for ocular drug delivery |
| WO2018031913A1 (en) | 2016-08-12 | 2018-02-15 | Clearside Biomedical, Inc. | Devices and methods for adjusting the insertion depth of a needle for medicament delivery |
| US12090294B2 (en) | 2017-05-02 | 2024-09-17 | Georgia Tech Research Corporation | Targeted drug delivery methods using a microneedle |
-
1995
- 1995-09-08 WO PCT/US1995/011316 patent/WO1996009838A1/en not_active Ceased
- 1995-09-08 AU AU35848/95A patent/AU3584895A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996009838A1 (en) | 1996-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL117793A0 (en) | Method for the treatment of macular degeneration | |
| AU5387796A (en) | Method and compositions for treating impotence | |
| AU6694596A (en) | Method and composition for treating asthma | |
| AU2593900A (en) | Composition and method for treating glaucoma | |
| AU7373096A (en) | Method for treating contaminated soils with ozone | |
| AU4668193A (en) | Method of treating ophthalmic disorders using tgf-beta | |
| AU4348597A (en) | Composition and method for repairing neurological tissue | |
| AU2464195A (en) | Method of performing laser therapy | |
| AU3584895A (en) | Method of treating macular degeneration using tgf-beta | |
| AU1935395A (en) | Method for treating conditions of the eye using polypeptides | |
| AUPN271295A0 (en) | Method of treatment | |
| ZA944323B (en) | Method for treating hypoxia-associated ocular complications | |
| AU3950297A (en) | Method of sterilising material for implantation | |
| AU7592991A (en) | Composition and method for controlling cholesterol | |
| AU1714697A (en) | Method and composition for the treatment of osteoarthritis | |
| AU3369595A (en) | Methods for inhibiting bone prosthesis degeneration | |
| AU1587495A (en) | Process for the treatment of contaminated land | |
| AU8003694A (en) | Method for treating coffee aromas | |
| IL109762A0 (en) | Method for treating hypoxia-associated ocular complications | |
| AU6165898A (en) | Method and apparatus for the treatment of strabismus | |
| AU2393500A (en) | Method for preventing and treating the degeneration of neurons | |
| AU4027097A (en) | Method of treatment | |
| AU6345699A (en) | Use of gndf for treating retinal degeneration | |
| AU7340694A (en) | Treatment of age-related macular degeneration | |
| AU3779595A (en) | Method of treating turf |